TrialSpark’s $156 Million Series C Financing

Fenwick & West advised TrialSpark on the deal.TrialSpark, a technology-driven pharma company that runs end-to-end clinical trials, announced its $156 million Series C financing. The round was…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here